Dementia with Lewy bodies (DLB) shares similarities with Alzheimer's disease and other dementias but is distinguished by the presence of Lewy bodies—abnormal protein deposits in the brain. These deposits can lead to a decline in thinking, reasoning, and independent function, akin to Alzheimer's. However, DLB often includes symptoms like visual hallucinations, fluctuating cognition, and motor impairments such as stiffness or tremors, which are more typical of Parkinson's disease.
Unlike Alzheimer's, where memory loss usually dominates early stages, DLB may first manifest with visual hallucinations or movement issues. Both conditions share overlapping features of cognitive decline and memory loss, yet DLB's unique symptoms challenge diagnosis and management. Treatment strategies differ slightly, emphasizing symptom management and tailored approaches to cognitive and behavioral symptoms specific to DLB's presentation. Understanding these distinctions is crucial for accurate diagnosis and effective management of each condition.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States